Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses

Background Evidence-based reassurances addressing vaccine-related concerns are crucial to promoting primary vaccination, completion of the primary series, and booster vaccination. By summarizing and comparing the reactogenicity of COVID-19 vaccines authorized by the European Medicines Agency, this a...

Full description

Bibliographic Details
Main Authors: Giorgia Tiozzo, Timon Louwsma, Stefan R A Konings, Gerard T Vondeling, Judith Perez Gomez, Maarten J Postma, Roel D Freriks
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Expert Review of Vaccines
Subjects:
Online Access:http://dx.doi.org/10.1080/14760584.2023.2208216